GPT Healthcare declares interim dividend, elevates leadership, reports Q2 earnings

GPT Healthcare Limited's board of directors approved the unaudited financial results for the second quarter and half year ended September 30, 2025. The company reported a profit after tax of ₹1,060.44 lakhs for the quarter and ₹1,828.62 lakhs for the half year. Total income for the half year stood at ₹22,891.78 lakhs. Basic earnings per equity share for the quarter and half year were ₹1.29 and ₹2.23, respectively.

In addition to the financial disclosures, the board declared an interim dividend of 10%, amounting to ₹1 per equity share of ₹10/- each for the financial year 2025-26. The record date for this dividend is fixed as Friday, November 14, 2025, with payment expected by December 7, 2025.

The company also announced leadership elevations, with Dr. Om Tantia appointed chairman and managing director and Mr. Shree Gopal Tantia elevated to vice chairman, both effective November 8, 2025. GPT Healthcare does not have any subsidiaries or associates, negating the need for consolidated financial results.